Literature DB >> 9292790

"Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis.

J F Fries1, D R Ramey.   

Abstract

OBJECTIVE: Quality-of-life assessment is receiving increased attention as an outcome measure in rheumatoid arthritis (RA). The most widely used instruments use variations on a vertical visual analog scale (VAS). Since the Health Assessment Questionnaire (HAQ), Arthritis Impact Measurement Scales (AIMS), and other instruments have long included a "global" arthritis horizontal VAS (GLOB), we studied whether these 2 approaches assess the same concept.
METHODS: We studied 663 patients with RA from 4 ARAMIS (Arthritis, Rheumatism, and Aging Medical Information System) centers and had them complete, in different parts of the same HAQ, the GLOB and the Torrance "feeling thermometer" (FT).
RESULTS: The 2 scales were highly correlated (r = -0.676; p < 0.001). Reliability (estimated by 6 month test-retest) was 0.62 for the FT and 0.83 for the GLOB. The GLOB correlated more strongly than the FT with disability (r = 0.561 vs -0.507) and pain (0.630 vs -0.553). In stepwise regressions, pain and then disability were the dominant predictors of both GLOB and FT, followed weakly by joint count and then other variables. Patients with greater disability placed more emphasis on pain and patients with greater pain appeared to value more the contribution of disability. Change scores over 6 months between GLOB and FT correlated very well (-0.59).
CONCLUSION: "Health" and "health related quality-of-life" are nearly equivalent terms. Since large longitudinal rheumatology databases contain thousands of global health VAS values, data for longitudinal quality-of-life studies in arthritis are already available, and this dimension may readily be added to longterm outcome assessment. In patients with RA, "generic" and "disease specific" assessments yield very similar results.

Entities:  

Mesh:

Year:  1997        PMID: 9292790

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

Review 1.  Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation.

Authors:  Lisa Kennedy; Ann-Marie Craig
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?

Authors:  A G E M de Boer; J J B van Lanschot; P F M Stalmeier; J W van Sandick; J B F Hulscher; J C J M de Haes; M A G Sprangers
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

3.  Quality of life in Indian patients with rheumatoid arthritis.

Authors:  Gurdesh S Bedi; Nikhil Gupta; Rohini Handa; Hemraj Pal; R M Pandey
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

4.  Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Authors:  Nasim Ahmed Khan; Horace Jack Spencer; Essam Ahmed Abda; Rieke Alten; Christof Pohl; Codrina Ancuta; Massimiliano Cazzato; Pál Géher; Laure Gossec; Dan Henrohn; Merete Lund Hetland; Nevsun Inanc; Johannes Wg Jacobs; Eduardo Kerzberg; Maria Majdan; Omondi Oyoo; Ruben A Peredo-Wende; Zahraa Ibrahim Selim; Fotini Nikolaos Skopouli; Alberto Sulli; Kim Hørslev-Petersen; Peter C Taylor; Tuulikki Sokka
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

5.  Do clinical marker states improve responsiveness and construct validity of the standard gamble and feeling thermometer: a randomized multi-center trial in patients with chronic respiratory disease.

Authors:  Holger J Schünemann; Roger Goldstein; M Jeffery Mador; Douglas McKim; Elisabeth Stahl; Lauren E Griffith; Ahmed M Bayoumi; Peggy Austin; Gordon H Guyatt
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

6.  Direct and Indirect Determinants of the Patient Global Assessment in Rheumatoid Arthritis: Differences by Level of Disease Activity.

Authors:  Michael M Ward; Lori C Guthrie; Abhijit Dasgupta
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

7.  Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory.

Authors:  James F Fries; Eswar Krishnan; Matthias Rose; Bharathi Lingala; Bonnie Bruce
Journal:  Arthritis Res Ther       Date:  2011-09-14       Impact factor: 5.156

8.  Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.

Authors:  Sean McKenna; Marie Tierney; Aoife O'Neill; Alexander Fraser; Norelee Kennedy
Journal:  Rheumatol Int       Date:  2018-03-14       Impact factor: 2.631

9.  Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.

Authors:  Johanna M Hazes; Peter Taylor; Vibeke Strand; Oana Purcaru; Geoffroy Coteur; Philip Mease
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

10.  Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.

Authors:  Jonathan Graf; Rebecca Scherzer; Carl Grunfeld; John Imboden
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.